搜索临床试验以:Metastatic BCC (mBCC)
总计14793个结果
-
Centre Hospitalier Universitaire Vaudois未知
-
Dartmouth-Hitchcock Medical CenterNational Cancer Institute (NCI); Norris Cotton Cancer Center完全的
-
AstraZeneca完全的肿瘤,鳞状细胞美国, 捷克共和国, 波兰, 德国, 比利时, 台湾, 印度, 塞尔维亚
-
National Cancer Centre, Singapore未知
-
Azienda Ospedaliera Ordine Mauriziano di Torino未知
-
CONKO-StudiengruppeEli Lilly and Company完全的
-
Achieve Life Sciences完全的癌,移行细胞 | 输尿管肿瘤 | 尿道肿瘤 | 膀胱肿瘤美国
-
Eli Lilly and Company完全的
-
Hellenic Oncology Research GroupUniversity Hospital of Crete完全的
-
AstraZenecaScandinavian Prostate Cancer Group完全的
-
Sanofi完全的乳腺癌美国, 法国, 加拿大, 德国, 意大利, 荷兰, 西班牙, 瑞士, 火鸡, 比利时, 阿根廷, 丹麦, 哥伦比亚, 大韩民国, 南非
-
The University of Texas Health Science Center,...未知
-
Threshold PharmaceuticalsPPD完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Hoffmann-La Roche; Genentech... 和其他合作者完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital完全的
-
AstraZeneca终止Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC芬兰
-
British Columbia Cancer AgencyNational Cancer Institute (NCI)完全的